Meeting
2019 Genitourinary Cancers Symposium
External beam radiation therapy and brachytherapy boost versus radical prostatectomy and adjuvant radiation therapy for high-risk prostate cancer.
Authors
Vinayak Muralidhar
Dana-Farber Cancer Institute, Boston, MA
Vinayak Muralidhar , Brandon Arvin Virgil Mahal , David Dewei Yang , Jonathan Eric Leeman , Anthony Victor D'Amico , Paul L. Nguyen , Peter F. Orio , Martin T. King
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 21)
DOI
10.1200/JCO.2019.37.7_suppl.21
Abstract #
21
Poster Bd #
B9
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Comparisons of outcomes for patients with high-risk prostate cancer treated with brachytherapy, external beam radiation, or radical prostatectomy.
First Author: Jay P. Ciezki
Poster
2023 ASCO Genitourinary Cancers Symposium
Results of a multicenter, randomized, phase 3 trial of trimodality therapy with I-125 brachytherapy, external beam radiation therapy, and long- versus short-term androgen deprivation therapy for localized high-risk prostate cancer (TRIP/TRIGU0907).
First Author: Atsunori Yorozu
Poster
2022 ASCO Genitourinary Cancers Symposium
Survival outcomes in men with unfavorable intermediate-risk and high-risk prostate cancer treated with prostate-only versus whole pelvic radiation therapy.
First Author: Neal Andruska
Poster
2020 Genitourinary Cancers Symposium
PSA status after neoadjuvant androgen deprivation therapy before high-dose-rate brachytherapy as biomarker for prediction of long-term outcome in high-risk prostate cancer patients.
First Author: Trude Wedde